Envestnet Asset Management Inc. lifted its holdings in M.D.C. Holdings, Inc. (NYSE:MDC) by 28.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,180 shares of the construction company’s stock after acquiring an additional 2,941 shares during the period. Envestnet Asset Management Inc.’s holdings in M.D.C. were worth $568,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Captrust Financial Advisors lifted its position in M.D.C. by 86.0% during the second quarter. Captrust Financial Advisors now owns 1,306 shares of the construction company’s stock worth $43,000 after purchasing an additional 604 shares during the period. C M Bidwell & Associates Ltd. bought a new position in shares of M.D.C. in the second quarter worth about $90,000. Cambridge Investment Research Advisors Inc. bought a new position in shares of M.D.C. in the second quarter worth about $218,000. GAM Holding AG bought a new position in shares of M.D.C. in the second quarter worth about $252,000. Finally, Zebra Capital Management LLC bought a new position in shares of M.D.C. in the second quarter worth about $267,000. Institutional investors and hedge funds own 74.42% of the company’s stock.

MDC has been the subject of a number of research reports. ValuEngine cut shares of M.D.C. from a “hold” rating to a “sell” rating in a report on Thursday, October 31st. Zelman & Associates cut shares of M.D.C. from a “buy” rating to a “hold” rating in a report on Thursday, October 31st. Raymond James raised shares of M.D.C. from an “outperform” rating to a “strong-buy” rating and increased their target price for the stock from $42.00 to $49.00 in a report on Friday, September 13th. Zacks Investment Research cut shares of M.D.C. from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Cfra raised shares of M.D.C. from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Hold” and an average price target of $44.00.

Shares of NYSE MDC opened at $38.71 on Wednesday. The company has a 50 day simple moving average of $42.59 and a 200 day simple moving average of $36.97. The firm has a market cap of $2.40 billion, a PE ratio of 10.55, a price-to-earnings-growth ratio of 1.03 and a beta of 1.04. M.D.C. Holdings, Inc. has a 1 year low of $25.77 and a 1 year high of $46.84. The company has a debt-to-equity ratio of 0.66, a current ratio of 9.08 and a quick ratio of 1.83.

M.D.C. (NYSE:MDC) last issued its quarterly earnings data on Wednesday, October 30th. The construction company reported $0.79 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.08). The business had revenue of $750.27 million during the quarter, compared to the consensus estimate of $767.23 million. M.D.C. had a net margin of 6.58% and a return on equity of 12.73%. The firm’s quarterly revenue was down 2.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.86 EPS. As a group, research analysts anticipate that M.D.C. Holdings, Inc. will post 3.54 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $1.20 dividend on an annualized basis and a yield of 3.10%. M.D.C.’s dividend payout ratio (DPR) is presently 32.70%.

In other M.D.C. news, Director Raymond T. Baker sold 41,250 shares of the stock in a transaction that occurred on Wednesday, September 18th. The shares were sold at an average price of $42.69, for a total transaction of $1,760,962.50. Following the completion of the sale, the director now owns 45,462 shares of the company’s stock, valued at approximately $1,940,772.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jean-Frederic Viret sold 3,159 shares of the stock in a transaction that occurred on Wednesday, September 18th. The shares were sold at an average price of $20.44, for a total transaction of $64,569.96. In the last quarter, insiders sold 98,832 shares of company stock valued at $4,248,023. 26.30% of the stock is owned by company insiders.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Recommended Story: Trade War

Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC).

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.